Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial
about
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial
description
scientific article published on 19 July 2019
@en
name
Baseline T1 hyperintense and d ...... patients of the GLARIUS trial
@en
type
label
Baseline T1 hyperintense and d ...... patients of the GLARIUS trial
@en
prefLabel
Baseline T1 hyperintense and d ...... patients of the GLARIUS trial
@en
P2093
P50
P1476
Baseline T1 hyperintense and d ...... patients of the GLARIUS trial
@en
P2093
Astrid Weyerbrock
Christian Borchers
Christina Schaub
Claus Belka
Clemens Seidel
Dietmar Krex
Frederic Mack
Friederike Schmidt-Graf
Hartmut Vatter
Joachim P Steinbach
P304
P356
10.1007/S11060-019-03246-4
P577
2019-07-19T00:00:00Z